Pfenex - 48 Year Dividend Yield History | PFNX

Historical dividend payout and yield for Pfenex (PFNX) since 1971. The current TTM dividend payout for Pfenex (PFNX) as of March 19, 2019 is $0.00. The current dividend yield for Pfenex as of March 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.155B $0.015B
Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf?nex Expression Technology (TM) platform to build a pipeline of product candidates and preclinical products under development including other biosimilars, as well as vaccines, generics and next generation biologics. Pfenex Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.048B 13.28
Gilead Sciences (GILD) United States $82.934B 10.56
Bio-Techne Corp (TECH) United States $7.430B 50.06